ReShape Lifesciences™ Announces Release of a Positive Consensus Statement on Lap-Band® Use and Lap-Band® Aftercare Management by the American Society of Metabolic and Bariatric Surgery (ASMBS)
Active ASMBS Members, Comprised of Lap-Band® Clinical Experts, Participated in a Consensus Process to Yield Recommendations for Optimal Aftercare
ASMBS Reasserts Endorsement of the Lap-Band® as a Safe and Effective Weight Loss Procedure
In order to formulate its Consensus Statement, the ASMBS Integrated Health Clinical Issues Committee surveyed a total of thirty-nine Lap-Band® surgeons and integrated health program members, considered to be experts in the management of Lap-Band® patients. A formal modified Delphi, 2-stage consensus approach was conducted on Lap-Band® management. Thirty-four consensus statements were developed following a literature search on a wide range of laparoscopic adjustable gastric band (LAGB) topics, and a 5-point Likert scale was implemented to measure consensus agreement among the participants, who agreed to participate in two rounds of Delphi questionnaires. Consensus was set a priori at 75% agreement, defined as the proportion of participants responding with agreement (i.e., 4 or 5) or disagreement (i.e., 1 or 2) on the Likert scale. Consensus Statements were then issued on six domains including behavioral health, nutrition, identification and management of weight loss complications, medical management, special populations and follow-up assessment of Lap-Band® patients.
“Lap-Band® management continues to be an important part of many metabolic and bariatric surgery practices, including my own,” stated
“Having the Lap-Band® recognized and endorsed in the new, Consensus Statement issued by ASMBS, one of the industry’s most important and influential organizations, is another validation that the anatomy-sparing Lap-Band® is a safe and effective weight loss solution. We are pleased to see that many of the determinations reached in the Statement, related to the six domains, align perfectly with ReShape’s own evidence-based, best practices recommendations,” stated
About ReShape Lifesciences™
ReShape Lifesciences™ is America's premier weight loss and metabolic health-solutions company, offering an integrated portfolio of proven products and services that manage and treat obesity and metabolic disease. The FDA-approved Lap-Band® Program provides minimally invasive, long-term treatment of obesity and is an alternative to more invasive surgical stapling procedures such as the gastric bypass or sleeve gastrectomy. Reshapecare™ is a virtual weight-management program that supports lifestyle changes for all weight-loss patients led by board certified health coaches to help them keep the weight off over time. The recently launched ReShape Marketplace™ is an online collection of quality wellness products curated for all consumers to help them achieve their health goals. The ReShape Vest™ System is an investigational (outside the
CONTACTS
ReShape Lifesciences Investor Contact:
Chief Financial Officer
949-276-6042
ir@ReShapeLifesci.com
Investor Relations Contact:
(917)-633-6086
mmiller@rxir.com
Source: ReShape Lifesciences Inc